Cargando…

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals

BACKGROUND: The functional polymorphism Val158Met in the catechol-O-methyltransferase (COMT) gene has been associated with differences in prefrontal cognitive functions in patients with schizophrenia and healthy individuals. Several studies have indicated that the Met allele is associated with bette...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchimine, Shoko, Yasui-Furukori, Norio, Kaneda, Ayako, Kaneko, Sunao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839926/
https://www.ncbi.nlm.nih.gov/pubmed/24282499
http://dx.doi.org/10.1371/journal.pone.0076763
_version_ 1782478456348475392
author Tsuchimine, Shoko
Yasui-Furukori, Norio
Kaneda, Ayako
Kaneko, Sunao
author_facet Tsuchimine, Shoko
Yasui-Furukori, Norio
Kaneda, Ayako
Kaneko, Sunao
author_sort Tsuchimine, Shoko
collection PubMed
description BACKGROUND: The functional polymorphism Val158Met in the catechol-O-methyltransferase (COMT) gene has been associated with differences in prefrontal cognitive functions in patients with schizophrenia and healthy individuals. Several studies have indicated that the Met allele is associated with better performance on measures of cognitive function. We investigated whether the COMT Val158Met genotype was associated with cognitive function in 149 healthy controls and 118 patients with schizophrenia. METHODS: Cognitive function, including verbal memory, working memory, motor speed, attention, executive function and verbal fluency, was assessed by the Brief Assessment of Cognition in Schizophrenia (BACS-J). We employed a one-way analysis of variance (ANOVA) and a multiple regression analysis to determine the associations between the COMT Val158Met genotype and the BACS-J measurements. RESULTS: The one-way ANOVA revealed a significant difference in the scores on the Tower of London, a measure of executive function, between the different Val158Met genotypes in the healthy controls (p = 0.023), and a post-hoc analysis showed significant differences between the scores on the Tower of London in the val/val genotype group (18.6 ± 2.4) compared to the other two groups (17.6 ± 2.7 for val/met and 17.1 ± 3.2 for met/met; p = 0.027 and p = 0.024, respectively). Multiple regression analyses revealed that executive function was significantly correlated with the Val158Met genotype (p = 0.003). However, no evidence was found for an effect of the COMT on any cognitive domains of the BACS-J in the patients with schizophrenia. CONCLUSION: These data support the hypothesis that the COMT Val158Met genotype maintains an optimal level of dopamine activity. Further studies should be performed that include a larger sample size and include patients on and off medication, as these patients would help to confirm our findings.
format Online
Article
Text
id pubmed-3839926
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38399262013-11-26 Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals Tsuchimine, Shoko Yasui-Furukori, Norio Kaneda, Ayako Kaneko, Sunao PLoS One Research Article BACKGROUND: The functional polymorphism Val158Met in the catechol-O-methyltransferase (COMT) gene has been associated with differences in prefrontal cognitive functions in patients with schizophrenia and healthy individuals. Several studies have indicated that the Met allele is associated with better performance on measures of cognitive function. We investigated whether the COMT Val158Met genotype was associated with cognitive function in 149 healthy controls and 118 patients with schizophrenia. METHODS: Cognitive function, including verbal memory, working memory, motor speed, attention, executive function and verbal fluency, was assessed by the Brief Assessment of Cognition in Schizophrenia (BACS-J). We employed a one-way analysis of variance (ANOVA) and a multiple regression analysis to determine the associations between the COMT Val158Met genotype and the BACS-J measurements. RESULTS: The one-way ANOVA revealed a significant difference in the scores on the Tower of London, a measure of executive function, between the different Val158Met genotypes in the healthy controls (p = 0.023), and a post-hoc analysis showed significant differences between the scores on the Tower of London in the val/val genotype group (18.6 ± 2.4) compared to the other two groups (17.6 ± 2.7 for val/met and 17.1 ± 3.2 for met/met; p = 0.027 and p = 0.024, respectively). Multiple regression analyses revealed that executive function was significantly correlated with the Val158Met genotype (p = 0.003). However, no evidence was found for an effect of the COMT on any cognitive domains of the BACS-J in the patients with schizophrenia. CONCLUSION: These data support the hypothesis that the COMT Val158Met genotype maintains an optimal level of dopamine activity. Further studies should be performed that include a larger sample size and include patients on and off medication, as these patients would help to confirm our findings. Public Library of Science 2013-11-25 /pmc/articles/PMC3839926/ /pubmed/24282499 http://dx.doi.org/10.1371/journal.pone.0076763 Text en © 2013 Tsuchimine et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tsuchimine, Shoko
Yasui-Furukori, Norio
Kaneda, Ayako
Kaneko, Sunao
Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
title Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
title_full Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
title_fullStr Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
title_full_unstemmed Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
title_short Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
title_sort differential effects of the catechol-o-methyltransferase val158met genotype on the cognitive function of schizophrenia patients and healthy japanese individuals
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839926/
https://www.ncbi.nlm.nih.gov/pubmed/24282499
http://dx.doi.org/10.1371/journal.pone.0076763
work_keys_str_mv AT tsuchimineshoko differentialeffectsofthecatecholomethyltransferaseval158metgenotypeonthecognitivefunctionofschizophreniapatientsandhealthyjapaneseindividuals
AT yasuifurukorinorio differentialeffectsofthecatecholomethyltransferaseval158metgenotypeonthecognitivefunctionofschizophreniapatientsandhealthyjapaneseindividuals
AT kanedaayako differentialeffectsofthecatecholomethyltransferaseval158metgenotypeonthecognitivefunctionofschizophreniapatientsandhealthyjapaneseindividuals
AT kanekosunao differentialeffectsofthecatecholomethyltransferaseval158metgenotypeonthecognitivefunctionofschizophreniapatientsandhealthyjapaneseindividuals